Tag: Multidisciplinary Association for Psychedelic Studies

November 18, 2020

What Does the FDA Think About Psychedelics?

The investigation of psychedelic drugs for their medical benefits is attracting investors. How does the leading US drug agency feel?
September 23, 2020

Psychedelic Therapies Emerging as Integrated Health Treatment Options

Psychedelic therapies including psilocybin are increasingly being considered for their remedial and medical benefits by health organizations across North America.
August 13, 2020

Medical Benefits Fueling Psychedelics Business Boost

INN chatted with Adele Byrne, senior analyst at Prohibition Partners, about the early start for the psychedelics market.